Metraipolis › archive › dc_cb73e0bae440

Lysosomal vulnerability as a therapeutic target in thyroid cancer using fucoidan nanoparticles — Europe PMC PMID:42120505

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42120505
DOI
10.1038/s41598-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-02T11:10:13.986Z
SHA-256 of the archived text
f82a68926ed4b01962b5ac683b536798148e99024e99b1bf76b8a30e8bd03803
Stable URL of this page
https://metraipolis.com/documento/dc_cb73e0bae440

How to cite

Lysosomal vulnerability as a therapeutic target in thyroid cancer using fucoidan nanoparticles — Europe PMC PMID:42120505 — Europe PMC (en), https://europepmc.org/article/MED/42120505 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cb73e0bae440 (Metraipolis archive dc_cb73e0bae440, sha256 f82a68926ed4b01962b5ac683b536798148e99024e99b1bf76b8a30e8bd03803)
BibTeX
@misc{dccb73e0bae440,
  title = {Lysosomal vulnerability as a therapeutic target in thyroid cancer using fucoidan nanoparticles — Europe PMC PMID:42120505},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42120505},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cb73e0bae440; sha256 f82a68926ed4b01962b5ac683b536798148e99024e99b1bf76b8a30e8bd03803},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42120505. Agents can read the archived copy with the MCP tool read_document.